Home Cart Sign in  
Chemical Structure| 26260-02-6 Chemical Structure| 26260-02-6

Structure of 2-Iodobenzaldehyde
CAS No.: 26260-02-6

Chemical Structure| 26260-02-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Synonyms: o-Iodobenzaldehyde

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 26260-02-6 ]

CAS No. :26260-02-6
Formula : C7H5IO
M.W : 232.02
SMILES Code : O=CC1=CC=CC=C1I
Synonyms :
o-Iodobenzaldehyde
MDL No. :MFCD00039570
InChI Key :WWKKTHALZAYYAI-UHFFFAOYSA-N
Pubchem ID :643439

Safety of [ 26260-02-6 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Computational Chemistry of [ 26260-02-6 ] Show Less

Physicochemical Properties

Num. heavy atoms 9
Num. arom. heavy atoms 6
Fraction Csp3 0.0
Num. rotatable bonds 1
Num. H-bond acceptors 1.0
Num. H-bond donors 0.0
Molar Refractivity 44.55
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

17.07 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

1.71
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

2.55
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

2.1
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

2.37
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

2.97
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

2.34

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-3.31
Solubility 0.113 mg/ml ; 0.000487 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-2.56
Solubility 0.645 mg/ml ; 0.00278 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-3.3
Solubility 0.115 mg/ml ; 0.000498 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

Yes
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

Yes
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-5.9 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

1.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

2.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

1.51

Application In Synthesis of [ 26260-02-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 26260-02-6 ]

[ 26260-02-6 ] Synthesis Path-Downstream   1~17

  • 1
  • [ 26260-02-6 ]
  • [ 62327-21-3 ]
  • [ 403705-03-3 ]
  • 2
  • [ 26260-02-6 ]
  • [ 53903-49-4 ]
  • [1-(2-Iodo-phenyl)-meth-(E)-ylidene]-(4-methoxy-2-trifluoromethyl-phenyl)-amine [ No CAS ]
  • 3
  • [ 26260-02-6 ]
  • [ 262373-15-9 ]
  • [ 2840-51-9 ]
  • [ 1705-89-1 ]
  • 4
  • [ 26260-02-6 ]
  • [ 252054-88-9 ]
  • [ 479-79-8 ]
  • 5
  • [ 26260-02-6 ]
  • [ 536-74-3 ]
  • [ 59046-72-9 ]
YieldReaction ConditionsOperation in experiment
92% With triethylamine; In water; at 20℃; for 8h; General procedure: An aryl halide (1.0 mmol) and a terminal alkyne (1.2 mmol) were added to a mixture of PS-tsu-Pd(II) complex (3) (0.001 mmol), triethylamine (2.0 mmol), and water (3 mL) in a round bottom flask under vigorous stirring. The mixture was stirred at room temperature for 8 h under aerobic conditions. After completion of the reaction, the mixture was filtered to recover the catalyst. The polymer was washed with water, acetonitrile and subjected to vacuum drying for the next run. Further, the reaction mixture was extracted with ethyl acetate and dried over MgSO4. The solvent was removed under reduced pressure and the residue was purified by column chromatography on silica gel using ethyl acetate/hexane as the eluent to give the corresponding coupling products.
66% With cetyltrimethylammonim bromide; potassium carbonate; In water; at 110℃; for 10h; General procedure: In a typical reaction, a mixture of aryl halides (1.2 mmol), phenylacetylene (1.5 mmol), K2CO3 (276 mg, 2 mmol), cetyltrimethylammonium bromide (36 mg, 0.1 mmol), H2O (3 mL) and catalyst 3 (30 mg, 0.03 mmol of Cu) was stirred at 110 C for 10 h, then cooled to room temperature, filtered and washed with ethyl acetate (3 × 10 mL). The combined organic layers were extracted with water, saturated brine solution, and dried over anhydrous Na2SO4. The organic layers were evaporated under reduced pressure and the resulting crude product was purified by column chromatography by using ethyl acetate/hexane (1:9) as eluent to give the corresponding product. All the products were confirmed by 1H, 13C NMR, and mass spectroscopic analysis. See the Supporting Information for full details.
  • 7
  • [ 26260-02-6 ]
  • [ 38980-96-0 ]
  • [ 1208259-10-2 ]
  • 8
  • [ 26260-02-6 ]
  • [ 57297-29-7 ]
  • [ 1208259-27-1 ]
  • 9
  • [ 118-48-9 ]
  • [ 26260-02-6 ]
  • [ 658-27-5 ]
  • [ 1370643-36-9 ]
  • 10
  • [ 26260-02-6 ]
  • [ 10328-92-4 ]
  • [ 658-27-5 ]
  • [ 1370643-42-7 ]
  • 11
  • [ 26260-02-6 ]
  • [ 1173707-01-1 ]
  • [ 109-77-3 ]
  • 10-fluoroindolo[1,2-a]quinazoline-7-carbonitrile [ No CAS ]
YieldReaction ConditionsOperation in experiment
48% General procedure: A dry sealed tube was charged with a magnetic stirrer, substitutedN-(2-iodophenyl)acetamide (100 mg for each example,0.38 mmol), malononitrile or 2-sulfonylacetonitriles(0.46 mmol, 1.2 equiv), CuI (0.038 mmol, 0.1 equiv), L-proline(0.076 mmol, 0.2 equiv), and K2CO3 (0.76 mmol, 2 equiv) in0.77 mL of DMSO. The tube was evacuated and backfilled withargon and the process was repeated three times. The mixturewas stirred at 80 °C for 12 h under an argon atmosphere.After the starting material was consumed completely,2-iodobenzaldehyde (0.4 mmol, 1.05 equiv) with 0.77 mL ofDMSO was charged successively to the tube via syringe,and then the resulting mixture was stirred at 80 °C foranother 12 h under an argon atmosphere. After thereaction was complete, the reaction mixture was cooledto room temperature and the reaction mixture was partitionedbetween ethyl acetate or dichloromethane and water. Theorganic layer was separated and the aqueous layer was extractedwith ethyl acetate or dichloromethane for three times. Thecombined organic solution was washed with water, brine, driedover anhydrous Na2SO4, and concentrated under reducedpressure to give the crude product. Purification by chromatographyon silica gel using petroleum ether/ethyl acetate ordichloromethane/ethyl acetate as eluent provided the desiredproduct.
  • 12
  • [ 26260-02-6 ]
  • [ 19591-17-4 ]
  • [ 109-77-3 ]
  • indolo[1,2-a]quinazoline-7-carbonitrile [ No CAS ]
YieldReaction ConditionsOperation in experiment
72% A dry sealedtube was charged with a magnetic stirrer, substituted <strong>[19591-17-4]N-(2-iodophenyl)acetamide</strong>(100 mg for each example, 0.38 mmol ), malononitrile or2-sulfonylacetonitriles(0.46 mmol, 1.2 equiv), CuI (0.038mmol, 0.1equiv),L-proline (0.076 mmol, 0.2 equiv), and K2CO3(0.76 mmol, 2 equiv) in 0.77 mL of DMSO. The tube wasevacuated and backfilled with argon and the process was repeated three times.The mixture was stirred at 80 C for 12 h under a argonatmosphere. After thestarting material was consumed completely, 2-iodobenzaldehyde (0.4 mmol, 1.05equiv) with 0.77 mL of DMSO was charged successively to the tube via syringe,and then the resulting mixture was stirred at 80 C for another 12 h underanargonatmosphere. After the reaction was complete, the reaction mixture wascooled to room temperature, the reaction mixture was partitioned between ethylacetate or dichloromethane and water. Organic layer was separated, and aqueouslayer was extracted with ethyl acetate or dichloromethane for three times, thecombined organic solution was washed with water, brine, dried over anhydrous Na2SO4, and concentrated under vacuum togive crude product. The crude product was purified by chromatography on silicagel (Petroleum ether/EtOAc = 4:1 as eluent) to give 4a. Yellow solid(67mg, 72%), mp 219-220 C; 1H NMR (500 MHz,[D6]DMSO) δ9.12 (s, 1H), 8.70 (d, J = 8.0 Hz, 1H), 8.62 (s, 1H),8.17 (d, J = 7.5 Hz, 1H), 8.01 (t, J = 7.4 Hz, 1H), 7.83 (s, 1H),7.64 (t, J = 7.5 Hz, 1H), 7.54 (d, J = 3.0 Hz, 2H); 13C NMR (126 MHz, [D6]DMSO) δ156.56, 146.69, 136.15,135.59, 130.44, 129.07, 127.41, 125.33, 124.54, 124.50, 119.05, 118.77, 115.66,115.63, 115.14, 78.23; MS (ESI, m/z) 244 [M+H]+; HRMS (ESI): calcd.for C16H9N3Na [M+Na]+ 266.0694, found 266.0696.
  • 13
  • [ 26260-02-6 ]
  • [ 19591-17-4 ]
  • [ 2274-42-2 ]
  • 7-(methylsulfonyl)indolo[1,2-a]quinazoline [ No CAS ]
YieldReaction ConditionsOperation in experiment
52% General procedure: A dry sealed tube was charged with a magnetic stirrer, substituted<strong>[19591-17-4]N-(2-iodophenyl)acetamide</strong> (100 mg for each example,0.38 mmol), malononitrile or 2-sulfonylacetonitriles(0.46 mmol, 1.2 equiv), CuI (0.038 mmol, 0.1 equiv), L-proline(0.076 mmol, 0.2 equiv), and K2CO3 (0.76 mmol, 2 equiv) in0.77 mL of DMSO. The tube was evacuated and backfilled withargon and the process was repeated three times. The mixturewas stirred at 80 C for 12 h under an argon atmosphere.After the starting material was consumed completely,2-iodobenzaldehyde (0.4 mmol, 1.05 equiv) with 0.77 mL ofDMSO was charged successively to the tube via syringe,and then the resulting mixture was stirred at 80 C foranother 12 h under an argon atmosphere. After thereaction was complete, the reaction mixture was cooledto room temperature and the reaction mixture was partitionedbetween ethyl acetate or dichloromethane and water. Theorganic layer was separated and the aqueous layer was extractedwith ethyl acetate or dichloromethane for three times. Thecombined organic solution was washed with water, brine, driedover anhydrous Na2SO4, and concentrated under reducedpressure to give the crude product. Purification by chromatographyon silica gel using petroleum ether/ethyl acetate ordichloromethane/ethyl acetate as eluent provided the desiredproduct.
  • 14
  • [ 26260-02-6 ]
  • [ 19591-17-4 ]
  • [ 7605-28-9 ]
  • 7-(phenylsulfonyl)indolo[1,2-a]quinazoline [ No CAS ]
YieldReaction ConditionsOperation in experiment
53% General procedure: A dry sealed tube was charged with a magnetic stirrer, substituted<strong>[19591-17-4]N-(2-iodophenyl)acetamide</strong> (100 mg for each example,0.38 mmol), malononitrile or 2-sulfonylacetonitriles(0.46 mmol, 1.2 equiv), CuI (0.038 mmol, 0.1 equiv), L-proline(0.076 mmol, 0.2 equiv), and K2CO3 (0.76 mmol, 2 equiv) in0.77 mL of DMSO. The tube was evacuated and backfilled withargon and the process was repeated three times. The mixturewas stirred at 80 C for 12 h under an argon atmosphere.After the starting material was consumed completely,2-iodobenzaldehyde (0.4 mmol, 1.05 equiv) with 0.77 mL ofDMSO was charged successively to the tube via syringe,and then the resulting mixture was stirred at 80 C foranother 12 h under an argon atmosphere. After thereaction was complete, the reaction mixture was cooledto room temperature and the reaction mixture was partitionedbetween ethyl acetate or dichloromethane and water. Theorganic layer was separated and the aqueous layer was extractedwith ethyl acetate or dichloromethane for three times. Thecombined organic solution was washed with water, brine, driedover anhydrous Na2SO4, and concentrated under reducedpressure to give the crude product. Purification by chromatographyon silica gel using petroleum ether/ethyl acetate ordichloromethane/ethyl acetate as eluent provided the desiredproduct.
  • 15
  • [ 1118-66-7 ]
  • [ 26260-02-6 ]
  • [ 14208-35-6 ]
  • 16
  • [ 26260-02-6 ]
  • [ 1986-47-6 ]
  • (1S*,2R*)-N-(2-iodobenzyl)-2-phenylcyclopropan-1-amine [ No CAS ]
YieldReaction ConditionsOperation in experiment
15% General procedure: Trans-2-phenylcyclopropylamine hydrochloride (1.0 eq.), acetic acid (1.0eq.) and the appropriate aldehyde (0.9 eq.) were dissolved in around bottom flask in 10 mL dry DCE. The reaction mixture was stirred gently at room temperature for 2 h before sodium triacetoxyborohydride (3.0 eq.) was added in small portions to the reaction vessel. The reaction was monitored by TLC and quenched using 10 mL of an aqueous (5%) NaHCO3 solution. The organic layer was separated and the aqueous layer extracted three times with10 mL of DCE. All organic layers were combined, dried over anhydrous Na2SO4, concentrated in vacuo and purified using flash chromatography (silica gel; cyclohexane/ethyl acetate) to give the desired compound.
  • 17
  • [ 26260-02-6 ]
  • [ 16155-03-6 ]
  • 2-(2-iodobenzyl)-4-methyl-1-(4-nitrophenyl)piperazine [ No CAS ]
 

Historical Records

Technical Information

• Alkyl Halide Occurrence • Barbier Coupling Reaction • Baylis-Hillman Reaction • Benzylic Oxidation • Birch Reduction • Blanc Chloromethylation • Bucherer-Bergs Reaction • Clemmensen Reduction • Complex Metal Hydride Reductions • Corey-Chaykovsky Reaction • Corey-Fuchs Reaction • Fischer Indole Synthesis • Friedel-Crafts Reaction • General Reactivity • Grignard Reaction • Hantzsch Dihydropyridine Synthesis • Henry Nitroaldol Reaction • Hiyama Cross-Coupling Reaction • Horner-Wadsworth-Emmons Reaction • Hydride Reductions • Hydrogenolysis of Benzyl Ether • Julia-Kocienski Olefination • Kinetics of Alkyl Halides • Knoevenagel Condensation • Leuckart-Wallach Reaction • McMurry Coupling • Meerwein-Ponndorf-Verley Reduction • Mukaiyama Aldol Reaction • Nozaki-Hiyama-Kishi Reaction • Passerini Reaction • Paternò-Büchi Reaction • Petasis Reaction • Pictet-Spengler Tetrahydroisoquinoline Synthesis • Preparation of Aldehydes and Ketones • Preparation of Alkylbenzene • Preparation of Amines • Prins Reaction • Reactions of Aldehydes and Ketones • Reactions of Alkyl Halides with Reducing Metals • Reactions of Amines • Reactions of Benzene and Substituted Benzenes • Reactions of Dihalides • Reformatsky Reaction • Schlosser Modification of the Wittig Reaction • Schmidt Reaction • Stetter Reaction • Stobbe Condensation • Substitution and Elimination Reactions of Alkyl Halides • Suzuki Coupling • Tebbe Olefination • Ugi Reaction • Vilsmeier-Haack Reaction • Wittig Reaction • Wolff-Kishner Reduction

Categories

Related Functional Groups of
[ 26260-02-6 ]

Aryls

Chemical Structure| 861118-00-5

A157263 [861118-00-5]

3,5-Diiodo-4-methylbenzaldehyde

Similarity: 0.90

Chemical Structure| 15164-44-0

A211346 [15164-44-0]

4-Iodobenzaldehyde

Similarity: 0.89

Chemical Structure| 696-41-3

A135649 [696-41-3]

3-Iodobenzaldehyde

Similarity: 0.87

Chemical Structure| 13329-40-3

A344622 [13329-40-3]

1-(4-Iodophenyl)ethanone

Similarity: 0.80

Chemical Structure| 1261470-87-4

A139500 [1261470-87-4]

4-Bromo-2-iodobenzaldehyde

Similarity: 0.79

Aldehydes

Chemical Structure| 861118-00-5

A157263 [861118-00-5]

3,5-Diiodo-4-methylbenzaldehyde

Similarity: 0.90

Chemical Structure| 15164-44-0

A211346 [15164-44-0]

4-Iodobenzaldehyde

Similarity: 0.89

Chemical Structure| 696-41-3

A135649 [696-41-3]

3-Iodobenzaldehyde

Similarity: 0.87

Chemical Structure| 1261470-87-4

A139500 [1261470-87-4]

4-Bromo-2-iodobenzaldehyde

Similarity: 0.79

Chemical Structure| 188813-09-4

A179901 [188813-09-4]

3-Bromo-5-iodobenzaldehyde

Similarity: 0.71